Amedisys Shareholders Face 56% Loss Over Five Years Despite Recent Gain

Amedisys' share price has declined by 56% over the past five years. However, the company's earnings per share (EPS) dropped by 8.1% annually during this period, which is less than the annual decline in the share price. This suggests that the market was previously too optimistic about the stock. Despite this, shareholders still gained a total return of 3.0% last year, indicating a potential turnaround in the business.